SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Steroidogenesis Inhibitors (STGI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bert Klimer who wrote (282)12/29/2001 2:07:52 PM
From: Jim Burnham  Read Replies (1) of 294
 
Bert,

Sapse is an eye doctor who isn't even a MD in the US (Did Jim Grace forget to tell you that). He has no publications. He is not qualified to talk to the FDA. The history of lies from this man is gut wrenching. You were sucked in by him as was I. But, I am fully behind management now that they have the Georgetown science team behind them. And afterwards, you have to admit that management has been a bit more careful with promises. In my opinion, that is because they are finally getting good information.

As for profit not being important. They could turn the entire company over to another company for X number of dollars. But during the lawsuits the company wouldn't have been worth squat. In fact the company still wouldn't be worth enough for the current investors (of which you aren't one) to be happy with. So, in fact, quick profit is not important.

If you truly want a voice in this company then buy some stock. From the viewpoint of a shareholder, you appear to be a bitter inexperienced stock trader.

Jim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News